| capecitabine / Generic mfg. |
NCT00909402: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas |
|
|
| Completed | 1b | 39 | US, Canada, Europe | BMS-833923, Cisplatin, Platinol-AQ, Capecitabine, Xeloda | Bristol-Myers Squibb, Exelixis | Stomach Neoplasms, Esophageal Neoplasms | 11/12 | 11/12 | | |
EMD 72000-024, NCT00113581: Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer |
|
|
| Completed | 1 | 26 | Europe | EMD 72000 (matuzumab) + ECX | Merck KGaA, Darmstadt, Germany | Esophageal Cancer, Gastric Cancer | 05/06 | 01/07 | | |
NCT00281788: Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer |
|
|
| Completed | 1 | 13 | US | capecitabine, carboplatin, paclitaxel, radiation therapy | Duke University, National Cancer Institute (NCI) | Esophageal Cancer | 07/07 | 07/07 | | |
NCT00238147: Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer |
|
|
| Completed | 1 | 18 | US | capecitabine, carboplatin, docetaxel, conventional surgery, neoadjuvant therapy, radiation therapy | University of Washington | Esophageal Cancer | | 08/08 | | |
NCT01225523: Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus |
|
|
| Completed | 1 | 350 | RoW | Paclitaxel; Cisplatin; 5-Fluorouracil, Paclitaxel; Cisplatin; 5-Fluorouracil; Capecitabine | Health Science Center of Xi'an Jiaotong University | Squamous Carcinoma of Esophagus, Esophagus Disorders | 12/08 | 01/10 | | |
NCT00368329: Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer |
|
|
| Terminated | 1 | 4 | US | Capecitabine (Xeloda), Xeloda, [18-F] Fluorodeoxyglucose (FDG), Fluorodeoxyglucose, 5-Fluorouracil (5-FU), 5-Fluorouracil, Carac, Efudix, Efudex, Fluoroplex, Carboplatin, cis-Diammine, Paraplatin, Paraplatin-AQ | Stanford University | Esophageal Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Esophageal Cancer | 03/09 | 03/09 | | |
NCT00153881: Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer |
|
|
| Completed | 1 | 44 | US | Capecitabine (Xeloda), Capecitabine, Carboplatin, Docetaxel | Dartmouth-Hitchcock Medical Center, Sanofi, Hoffmann-La Roche | Esophageal Neoplasms | 09/13 | 09/13 | | |
VEOX, NCT01386346: Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer |
|
|
| Completed | 1 | 12 | US | Azacitidine, Vidaza®, 5-Azacitidine, Oxaliplatin, Eloxatin, Epirubicin, Ellence, Capecitabine, Xeolda | Weill Medical College of Cornell University, Celgene Corporation | Esophageal Cancer, Malignant Neoplasm of Cardio-esophageal Junction of Stomach | 08/14 | 09/18 | | |
